Results 281 to 290 of about 269,977 (355)

Cancer Vaccines: Recent Insights and Future Directions. [PDF]

Int J Mol Sci
Malacopol AT, Holst PJ.
europepmc   +1 more source

Premalignant Lesions as Targets for Cancer Vaccines [PDF]

, 2003
Olivera J. Finn
openalex   +1 more source

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway

Cancer Communications, EarlyView.
Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei   +11 more
wiley   +1 more source

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy. [PDF]

Biomark Res
Shariati A, Khani P, Nasri F, Afkhami H, Khezrpour A, Kamrani S, Shariati F, Alavimanesh S, Modarressi MH.   +8 more
europepmc   +1 more source

Cancer Vaccine Therapy as Tumor Dormancy Therapy against Advamced Digestive Tract Cancer.

, 2001
Yuji Ueda, Tsuyoshi Itoh, Kaori Okugawa, Hitoshi Fujiwara, Nobuaki Fuji, Tetsunori Yoshimura, Tetsuro Yamashita, Hiroshi Fujiki, Sachio Harada, Hisakazu Yamagishi   +9 more
openalex   +2 more sources

Combating cancer immunotherapy resistance: a nano‐medicine perspective

Cancer Communications, EarlyView.
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong, Xintong Xie, Juan Wu, Xiangyu Wang, Wenxiang Zhang, Shuowen Wang, Daria Valerievna Abbasova, Yi Fang, Hongnan Jiang, Jidong Gao, Jing Wang   +10 more
wiley   +1 more source

Innovative Cancer Immunotherapy with MAGE-A3 mRNA Cancer Vaccines. [PDF]

Cancers (Basel)
Choi K, Jeong H, Lee DH, Lee JW, Hong JE, Baek JE, Park YS.   +6 more
europepmc   +1 more source

Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy. [PDF]

Front Immunol
Laila UE, An W, Xu ZX.
europepmc   +1 more source

Personalized neoantigen cancer vaccines: current progression, challenges and a bright future. [PDF]

Clin Exp Med
Wu DW, Jia SP, Xing SJ, Ma HL, Wang X, Tang QY, Li ZW, Wu Q, Bai M, Zhang XY, Fu XF, Jia MM, Tang Y, Chen L, Li N.   +14 more
europepmc   +1 more source

Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy

, 2002
Ulrich Keilholz, Jeffrey S. Weber, James H. Finke, Dmitry I. Gabrilovich, W. Martin Kast, Mary L. Disis, John M. Kirkwood, Carmen Scheibenbogen, Jeff Schlom, Vernon C. Maino, H. Kim Lyerly, Peter P. Lee, Walter J. Storkus, Franceso Marincola, Alexandra S. Worobec, Michael B. Atkins   +15 more
openalex   +1 more source